![]() |
市場調查報告書
商品編碼
1833687
醫療旅遊市場機會、成長動力、產業趨勢分析及2025-2034年預測Medical Tourism Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年全球醫療旅遊市場價值為 305 億美元,預計到 2034 年將以 16.8% 的複合年成長率成長至 1,420 億美元。
推動市場成長的因素包括政府簡化跨境醫療旅遊的措施、發展中地區可負擔治療方案的可用性以及慢性病患者數量的增加。採用國際公認的手術標準也增強了人們對海外醫療程序的信心。亞太地區各國已成為重要的醫療中心,以較低的成本提供先進的護理,同時為國際患者提供專門的資源。來自西方國家的遊客經常選擇這些目的地來獲得優質的醫療服務,其中相當一部分人還將治療與短期健康或康復之旅結合起來。醫療旅遊的吸引力不僅在於價格實惠,還在於更短的等待時間、現代化的基礎設施和專業的照護。人們的健康意識不斷提高,加上對選擇性手術和生活方式相關治療的需求不斷成長,繼續推動醫療旅遊的發展。這些因素共同作用,使醫療旅遊成為全球患者的首選,市場也迅速調整以滿足全球需求。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 305億美元 |
預測值 | 1420億美元 |
複合年成長率 | 16.8% |
2024年,美容整形手術市場佔17%,這得益於旨在改善外觀的手術日益普及,而創新技術也使治療更加安全、精準和微創。更快的恢復期和更低的成本鼓勵了更多患者追求美容。數位平台的影響力日益增強,也提高了人們的認知度,尤其是在年輕人群中,這進一步刺激了美容治療的需求,並擴大了其在醫療旅遊中的作用。
2024年,國際醫療佔有率佔比53.5%,反映出尋求海外治療的患者數量穩定成長。出國就醫的吸引力在於能夠獲得先進的診療方案、降低費用,以及避開在本國冗長的候診名單。這種轉變增強了發展中國家在提供高品質醫療服務的同時保持成本競爭力的地位。來自不同地區的患者繼續選擇此類目的地作為滿足多樣化醫療需求的首選,這進一步強化了該行業的全球化特徵。
2024年,歐洲醫療旅遊市場佔36.5%的市場佔有率,預計未來幾年將大幅擴張。許多來自北美、中東及周邊國家的患者更青睞歐洲目的地,因為歐洲擁有先進的醫療基礎設施和相對較低的治療成本。歐洲一些國家仍然是吸引多學科患者的主要中心,確保在全球市場擴張中發揮重要作用。
醫療旅遊市場的主要參與者包括萊佛士醫療集團、納拉亞納健康集團、約翰霍普金斯醫院、馬克斯醫療保健、馬卡蒂醫療中心、富通醫療有限公司、梅奧診所、聖路加醫療中心、安納多盧醫療中心、康民國際醫院、KPJ 醫療保健有限公司、質子治療中心、伊麗莎白醫院、阿波羅醫院集團、康民國際醫院、KPJ 醫療保健有限公司、質子治療中心、伊麗莎白醫院、阿波羅醫院集團、克利夫蘭愛犬市閣、Skle KlinS Kliner
為了鞏固市場地位,醫療旅遊公司正推行多元化策略。領先的醫院和醫療保健集團正在擴大與旅行社、保險公司和健康中心的合作,提供涵蓋治療、住宿和後續護理的綜合套餐。他們正在大力投資先進的醫療技術和基礎設施,以確保醫療服務達到國際認可的標準。許多機構也透過客製化的行銷活動、多語言服務和專門的國際患者部門來瞄準海外患者。透過衛星設施和與地區醫院的合作拓展新興市場,有助於提高醫療服務的可近性並建立對病患的信任。包括遠距醫療諮詢和線上預約平台在內的數位轉型進一步擴大了服務範圍,同時提升了整體患者體驗。
The Global Medical Tourism Market was valued at USD 30.5 billion in 2024 and is estimated to grow at a CAGR of 16.8% to reach USD 142 billion by 2034.
Market growth is driven by government initiatives that simplify cross-border medical travel, the availability of affordable treatment options in developing regions, and the increasing number of patients suffering from chronic illnesses. The adoption of internationally recognized surgical standards has also encouraged confidence in medical procedures abroad. Countries across the Asia Pacific have emerged as prominent hubs, offering advanced care at lower costs while dedicating specialized resources to international patients. Travelers from Western nations often seek these destinations for quality medical services, and a considerable portion also combine their treatment with short wellness or recovery-focused trips. The appeal lies not only in affordability but also in shorter waiting periods, modern infrastructure, and specialized care. Rising health awareness, coupled with growing demand for elective procedures and lifestyle-related treatments, continues to fuel momentum. Together, these factors are establishing medical tourism as a preferred option for patients worldwide, with markets adapting rapidly to meet global demand.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $30.5 Billion |
Forecast Value | $142 Billion |
CAGR | 16.8% |
The cosmetic surgery segment held a 17% share in 2024, driven by the increasing popularity of procedures aimed at improving physical appearance, supported by innovations that have made treatments safer, more precise, and minimally invasive. Faster recovery periods and reduced costs have encouraged more patients to pursue cosmetic enhancements. The growing influence of digital platforms has also heightened awareness, especially among younger demographics, further boosting demand for cosmetic treatments and expanding their role within medical tourism.
The international segment held a 53.5% share in 2024, reflecting the steady rise in patients seeking treatment abroad. The appeal of traveling for healthcare includes access to advanced procedures, reduced expenses, and the opportunity to bypass lengthy waiting lists in home countries. This shift has strengthened the position of developing nations that provide high-quality services while remaining cost-competitive. Patients from various regions continue to select such destinations as preferred choices for diverse medical needs, reinforcing the global nature of this industry.
Europe Medical Tourism Market held a 36.5% share in 2024 and is projected to expand significantly in the years ahead. Many patients from North America, the Middle East, and neighboring countries prefer European destinations due to the combination of advanced healthcare infrastructure and relatively lower treatment costs. Several countries within Europe remain leading centers for attracting patients across multiple specialties, ensuring a strong role in global market expansion.
Key players in the Medical Tourism Market include Raffles Medical Group, Narayana Health, Johns Hopkins Hospital, Max Healthcare, Makati Medical Center, Fortis Healthcare Limited, Mayo Clinic, St. Luke's Medical Center, Anadolu Medical Center, Bumrungrad International Hospital, KPJ Healthcare Berhad, Proton Therapy Center, Mount Elizabeth Hospitals, Apollo Hospitals Group, Mahkota Medical Centre, Gleneagles Hospital, Asklepios Kliniken GmbH & Co. KGaA, and Cleveland Clinic.
To reinforce their market position, companies in medical tourism are pursuing diverse strategies. Leading hospitals and healthcare groups are expanding partnerships with travel agencies, insurance providers, and wellness centers to offer comprehensive packages that include treatment, accommodation, and aftercare. Significant investments are being made in advanced medical technologies and infrastructure to ensure internationally accredited standards of care. Many organizations are also targeting overseas patients with tailored marketing campaigns, multilingual services, and dedicated international patient departments. Expansion into emerging markets through satellite facilities and affiliations with regional hospitals helps increase accessibility and build trust among patients. Digital transformation, including telemedicine consultations and online booking platforms, has further strengthened outreach while enhancing the overall patient experience.